Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection.
about
Filovirus research in Gabon and equatorial Africa: the experience of a research center in the heart of AfricaThe role of NK cells in HIV-1 protection: autologous, allogeneic or both?NK cell receptor/H2-Dk-dependent host resistance to viral infection is quantitatively modulated by H2q inhibitory signalsKiller-cell immunoglobulin-like receptors (KIR) in severe A (H1N1) 2009 influenza infections.Different features of Vδ2 T and NK cells in fatal and non-fatal human Ebola infections.Association of HLA class-I and inhibitory KIR genotypes in Gabonese patients infected by Chikungunya or Dengue type-2 viruses.Innate immune genes synergize to predict increased risk of chronic disease in hepatitis C virus infection.Evaluation of perceived threat differences posed by filovirus variants.Possible association of killer cell immunoglobulin-like receptor genotypes and haplotypes with dry eye disease in a Han Chinese populationPolymorphic HLA-C Receptors Balance the Functional Characteristics of KIR Haplotypes.Killer cell immunoglobulin-like receptor gene associations with autoimmune and allergic diseases, recurrent spontaneous abortion, and neoplasms.Roles of natural killer cells in antiviral immunityKiller Cell Immunoglobulin-like Receptor Genotype and Haplotype Investigation of Natural Killer Cells from an Australian Population of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Patients.Variable NK cell receptors and their MHC class I ligands in immunity, reproduction and human evolution.Activating killer cell Ig-like receptors in health and disease.Maternal KIR and fetal HLA-C: a fine balance.Correlates of immunity to filovirus infection.Protective role of cytotoxic T lymphocytes in filovirus hemorrhagic fever.Influence of KIR genes and their HLA ligands in susceptibility to dengue in a population from southern Brazil.Ebola virus: melatonin as a readily available treatment option.NK cells: tuned by peptide?Missing or altered self: human NK cell receptors that recognize HLA-C.Longitudinal peripheral blood transcriptional analysis of a patient with severe Ebola virus disease.A study of KIR genes and HLA-C in Vogt-Koyanagi-Harada disease in Saudi Arabia.Peptide-specific engagement of the activating NK cell receptor KIR2DS1.Diversity of killer cell immunoglobulin-like receptor genes in the Bai ethnic minority of Yunnan, China.Genetic polymorphism analysis of killer cell immunoglobulin-like receptor genes in the Chinese Uygur population.Natural killer cell education in human health and disease.Different Selected Mechanisms Attenuated the Inhibitory Interaction of KIR2DL1 with C2+ HLA-C in Two Indigenous Human Populations in Southern Africa.Human leukocyte antigen-C and killer cell immunoglobulin-like receptor gene polymorphisms among patients with syphilis in a Chinese Han population.The Ebola-Glycoprotein Modulates the Function of Natural Killer Cells
P2860
Q24273305-5675DFB1-1024-475D-AD08-08A03AB1E8A7Q26753146-B03A832C-FAE2-4640-A8EF-4DBEDF9BDA83Q27342452-FCEA119C-163D-4245-AF5A-0534B137D599Q30417443-D4FD8C89-2804-43F4-9AA9-F04DAC0349B2Q33803364-9329DB97-B84B-49FC-AF4E-C86A9EAC1456Q34275095-92616F56-524E-4CD9-9359-5F7EE549AA98Q34804539-6A6C773E-A50A-420B-9367-715EFDA67FE5Q35601783-B9554B1B-CBBA-41B6-958C-DCBA18900A78Q35994403-ED999374-6A06-4478-A496-803B50F5D8ACQ36075234-E1995FDB-7472-41AE-BEBF-260CCBE7C1A5Q36569959-9D5721A1-EEC0-4D69-A33E-B5187051F8D3Q36767761-0C2B055D-4ACB-4A5F-9A7F-4E56317CCB07Q37021151-08C502C8-C38E-43B7-8A97-CD38DC3642D9Q37641722-B5BEE637-47F6-47C6-B682-65DC17A2F787Q37725657-43210B11-4AE3-4F8D-A913-6B8ABE6A8462Q37923237-9015EED4-6973-4E13-B8D9-0A73DEB7070CQ37945233-96072B1F-D5C3-425A-913D-00C19D22E597Q37976671-C913A7EF-CF21-43CA-93F1-79E850802595Q38309142-8E119B67-5883-48A3-80BE-3B75D4F85BF3Q38328156-3A7667E6-9B80-4587-AF3F-83AC0899DB10Q38568884-20A33C5C-9417-4299-B57D-85031C10320AQ39427580-138D3E3E-62E3-436A-85E4-4EB8AE1148D3Q40061262-9266190C-DC1D-42B0-9570-C429B7D16966Q40127737-740425CB-92FE-495F-AD26-E41821993710Q40184605-F5984043-D445-49FC-866E-B3D925347274Q44461967-E8CD6C33-2A9E-4647-84BD-D92CDA6CA7C2Q46218661-CC162D99-B9AF-47E2-B413-9794910B5411Q50137212-3C4A3FCE-F3D0-44A1-A1E1-2D4FF58B17A9Q51146989-758D80FE-95A8-4A2C-95CC-5C45E3E850A0Q54293382-656694C9-5290-4BE8-BAB5-9D48D0AB98E4Q56911466-AF170F0B-50DD-4C28-89D3-16211249970B
P2860
Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection.
@ast
Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection.
@en
Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection.
@nl
type
label
Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection.
@ast
Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection.
@en
Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection.
@nl
prefLabel
Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection.
@ast
Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection.
@en
Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection.
@nl
P2093
P2860
P1433
P1476
Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection.
@en
P2093
Cindy Padilla
Nadia Wauquier
Pierre Becquart
Vincent Vieillard
P2860
P2888
P304
P356
10.1007/S00251-010-0480-X
P407
P577
2010-09-29T00:00:00Z
P5875
P6179
1006463048